Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes

    Early insulin therapy is capable to achieve glycemic control and restore β-cell function in newly diagnosed type 2 diabetes (T2D), but its effect on cardiovascular outcomes in these patients remains unclear. I...

    Sihui Luo, Xueying Zheng, Wei Bao, Sheng Nie in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study

    The safety and efficacy of COVID-19 vaccines in the elderly, a high-risk group for severe COVID-19 infection, have not been fully understood. To clarify these issues, this prospective study followed up 157 eld...

    Hong-Hong Liu, Yunbo **e, Bao-Peng Yang in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    The gasdermin family: emerging therapeutic targets in diseases

    The gasdermin (GSDM) family has garnered significant attention for its pivotal role in immunity and disease as a key player in pyroptosis. This recently characterized class of pore-forming effector proteins is...

    Chenglong Zhu, Sheng Xu, Ruoyu Jiang, Yizhi Yu in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  5. Article

    Open Access

    Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses

    The Orthopoxvirus genus, especially variola virus (VARV), monkeypox virus (MPXV), remains a significant public health threat worldwide. The development of therapeutic antibodies against orthopoxviruses is largely...

    Hang Chi, Suo-Qun Zhao, Ru-Yi Chen in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl concentration

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection disrupts the epithelial barrier and triggers airway inflammation. The envelope (E) protein, a core virulence structural component of coron...

    Jian-Bang Xu, Wei-Jie Guan, Yi-Lin Zhang in Signal Transduction and Targeted Therapy (2024)

  7. Article

    Open Access

    New clinical trial design in precision medicine: discovery, development and direction

    In the era of precision medicine, it has been increasingly recognized that individuals with a certain disease are complex and different from each other. Due to the underestimation of the significant heterogene...

    **ao-Peng Duan, Bao-Dong Qin, **ao-Dong Jiao in Signal Transduction and Targeted Therapy (2024)

  8. Article

    Open Access

    Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis

    Chu **e, Cong Sun, Mu-Sheng Zeng in Signal Transduction and Targeted Therapy (2024)

  9. Article

    Open Access

    Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

    The human gastrointestinal tract is populated with a diverse microbial community. The vast genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every aspect of human biology, ...

    Jian Sheng Loh, Wen Qi Mak, Li Kar Stella Tan in Signal Transduction and Targeted Therapy (2024)

  10. Article

    Open Access

    Host cyclophilin A facilitates SARS-CoV-2 infection by binding and stabilizing spike on virions

    **angpeng Sheng, Fang Zhu, Hong Peng, Fan Yang in Signal Transduction and Targeted Therapy (2023)

  11. Article

    Open Access

    Immunity-and-matrix-regulatory cells enhance cartilage regeneration for meniscus injuries: a phase I dose-escalation trial

    Immunity-and-matrix-regulatory cells (IMRCs) derived from human embryonic stem cells have unique abilities in modulating immunity and regulating the extracellular matrix, which could be mass-produced with stab...

    Liangjiang Huang, Song Zhang, Jun Wu in Signal Transduction and Targeted Therapy (2023)

  12. Article

    Open Access

    Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge

    Coronavirus disease 2019 (COVID-19) was first reported three years ago, when a group of individuals were infected with the original SARS-CoV-2 strain, based on which vaccines were developed. Here, we develop s...

    Qianyun Liu, Haiyan Zhao, Zhiqiang Li in Signal Transduction and Targeted Therapy (2023)

  13. Article

    Open Access

    High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA

    Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease undergoes various modifications, becomes dysfunctional (dHDL), and...

    Zhi-Wei Mo, Yue-Ming Peng, Yi-**n Zhang, Yan Li in Signal Transduction and Targeted Therapy (2023)

  14. Article

    Open Access

    Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis

    T lymphopenia, occurring in the early phase of sepsis in response to systemic inflammation, is commonly associated with morbidity and mortality of septic infections. We have previously shown that a sufficient ...

    Sheng-yuan Zhang, Qiu-** Xu, Li-na Shi in Signal Transduction and Targeted Therapy (2023)

  15. Article

    Open Access

    Molecular mechanisms underlying the high mortality of hypervirulent Klebsiella pneumoniae and its effective therapy development

    Qi Xu, Miaomiao **e, **aoxuan Liu, Heng Heng in Signal Transduction and Targeted Therapy (2023)

  16. Article

    Open Access

    Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines

    The ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused devastating impacts on the public health and the global ec...

    Liyan Guo, Sheng Lin, Zimin Chen, Yu Cao in Signal Transduction and Targeted Therapy (2023)

  17. Article

    Open Access

    Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

    **n Peng, Yingying Wang, Shaolu Zhang in Signal Transduction and Targeted Therapy (2023)

  18. Article

    Open Access

    Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies

    Despite the success of targeted therapies in cancer treatment, therapy-induced resistance remains a major obstacle to a complete cure. Tumor cells evade treatments and relapse via phenotypic switching driven b...

    Zhen-Duo Shi, Kun Pang, Zhuo-Xun Wu, Yang Dong in Signal Transduction and Targeted Therapy (2023)

  19. Article

    Open Access

    PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway

    Our previous studies have showed that C-C motif chemokine ligand 20 (CCL20) advanced tumor progression and enhanced the chemoresistance of cancer cells by positively regulating breast cancer stem cell (BCSC) s...

    Rui Zhang, Mengxue Dong, Juchuanli Tu in Signal Transduction and Targeted Therapy (2023)

  20. Article

    Open Access

    From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism

    Alternative splicing (AS) is an important approach for pathogens and hosts to remodel transcriptome. However, tuberculosis (TB)-related AS has not been sufficiently explored. Here we presented the first landsc...

    Mengyuan Lyu, Jian Zhou, Yanbing Zhou in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 4